How a neural network recognizes rapamycin treatment
In a lab where patient data resemble a scattering of gold dust, every test is a speck, and Alzheimer's disease is a river washing away the precious metal. Scientists set a task for the neural network: to tell whether a person received rapamycin, a drug that slows cellular aging, or not.